利尿藥公開課_第1頁
利尿藥公開課_第2頁
利尿藥公開課_第3頁
利尿藥公開課_第4頁
利尿藥公開課_第5頁
已閱讀5頁,還剩52頁未讀, 繼續(xù)免費閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)

文檔簡介

利尿藥公開課Chapter26目的了解各類利尿藥的作用部位,掌握呋塞米(速尿),氫氯噻嗪類,螺內(nèi)酯,氨苯喋啶(三氨喋啶),甘露醇等的作用,應(yīng)用,不良反應(yīng)。Chapter26內(nèi)容利尿藥的定義。復(fù)習(xí)泌尿生理過程,說明各段腎小管的再吸收及分泌功能。聯(lián)系說明各類利尿藥排電解質(zhì)的情況。利尿藥在治療水腫,高血壓,心力衰竭時的意義。利尿藥按作用部位的分類。主要作用于近曲小管的利尿藥:碳酸酐酶抑制劑醋唑磺胺,弱效,排出HCO3-的堿性尿。Chapter26內(nèi)容主要作用于髓袢升支的利尿藥:呋塞米,布美他尼的利尿作用,特點,強效,速效。抑制髓袢升支粗段的髓質(zhì)段和皮質(zhì)段的Na+-K+-2Cl-共同轉(zhuǎn)運系統(tǒng),抑制其對Cl-的主動再吸收及Na+的被動再吸收。抑制腎臟的濃縮和稀釋功能。臨床應(yīng)用于嚴重水腫,急性肺水腫和腦水腫,腎功能衰竭等。不良反應(yīng)。簡述丁苯氧酸的作用和應(yīng)用。主要作用于髓袢升支皮質(zhì)段的利尿藥:噻嗪類藥物:以氫氯噻嗪為例說明這類藥物利尿作用的特點,中效。作用在髓袢升支粗段對Na+-Cl-共同轉(zhuǎn)運系統(tǒng)。降壓作用。治療尿崩癥的作用。不良反應(yīng)。比較同類藥物的利尿強度。附氯噻酮。Chapter26內(nèi)容主要作用于遠曲小管和集合管的利尿藥:這類藥物的作用特點,留鉀,弱效。抑制遠曲小管和集合管的Na+-K+交換,排Na+留K+。螺內(nèi)酯(安體舒通)對抗醛固酮而利尿。氨苯喋啶直接抑制Na+的再吸收。臨床應(yīng)用。不良反應(yīng)。附氨氯吡咪。中草藥:簡述澤瀉,茯苓,豬苓,車前的利尿效果。脫水劑:定義。甘露醇與山梨醇的脫水作用及滲透性利尿作用。應(yīng)用與不良反應(yīng)。高滲葡萄糖的脫水作用。DiureticsDefinitionRenaltubuletransportmechanismsClassificationofdiureticsHighefficacydiuretics(Loopdiuretics)DiureticAgentsModerateefficacydiureticsLowefficacydiureticsClinicalusesofdiureticsOsmoticagentsDiureticAgentsDefinitionDiureticagentsareactingontherenaltubules,increaseexcretionofelectrolytes&water,increasetheamountofurine.Theyareusedtotreatedemacausedbyvariousdiseases,andalsotreatsomenon-edemadiseases,e.g.hypertension,renalstones,hypercalcaemia.DiureticAgentsRenaltubuletransportmechanismsProximaltubuleLoopofhenleDistalconvolutedtubuleCollectingtubuleDiureticAgentsClassificationofdiureticsHighefficacydiuretics(Loopdiuretics)Moderateefficacydiuretics(thiazides)LowefficacydiureticsDiureticAgentsHighefficacydiuretics(Loopdiuretics)Furosemide(呋塞米)Bumetanide(布美他尼)Torasemide(托拉塞米)Etacrynicacid(依他尼酸)DiureticAgentsFurosemide(呋塞米)Absorbedrapidlybyoral,F=40%,duration4-6hr.AfterIV,theeffectsoffurosemideresponsewithin5mins,duration2-3hr.Proteinbindingis95%.T1/2=1hr,itmaybeprolongto10hrs.inrenaldysfunction.DiureticAgentsPharmacologicaleffectsDiureticeffectsarerapid,strongandshort,dependentondose;individualdifferentia;InhibitionofNa+-K+-2Cl―co-transportsysteminthethickascendinglimboftheloopofhenle,↓diluteandconcentratefunctionsofkidney,excretelargerisotonicurine.DiureticAgentsTheycancause30-40%offilteredsodiumtobeexcreted,accordingtotheirnatriureticcapacity,loopdiureticsarehighlyefficacious.LargeamountsofNa+,Cl―,K+anddivalentcations(Ca2+,Mg2+)areexcretedandCl―lossismorethanNa+inurine.DiureticAgentsDecreaserenalvascularresistance;increaserenalbloodflowandcauseredistributionofbloodflowwithintherenalcortex.Increasereninrelease,prostacyclinmayplayanimportantroleinmediatingthereninreleaseresponsetoloopdiuretics.DiureticAgentsImprovepulmonarycongestionandreduceleftventricularfillingpressuresbyincreasingsystemicvenouscapacitance.Inhibitelectrolytetransportininnerear,alteratetheelectrolytecompositionofendolympha,thismaycontributetodruginducedototoxity.DiureticAgentsUsesSeriousedemaedemaofnephroticsyndrome,nephrosis;ascitesoflivercirrhosisoredemapatientswhodonotrespondtosaltrestrictionsorthiazides;chroniccongestiveheartfailuretominimizevenousandpulmonarycongestion.DiureticAgentsAcutepulmonaryedema&brainedemaPreventandtreatacuteorchronicrenalfailurefurosemidecanincreasetheratesofurineflowandenhanceK+excretioninacuterenalfailureDiureticAgentsPromoteexcretionoftoxicsubstancesOthersTreathypertensioncrisisTreatacutehypercalcaemiaTreathyperkalemiaDiureticAgentsSideeffectsWaterandElectrolytedisturbancehypovalume,hypokalemia,hyponatremia,hypomagnesemia,hypochloremicmetabolicalkalosis.Duringdiuretictherapy,hypokalemiaisthemostcommon.Alsocommonlysecondarytosevereliverdiseaseorcongestivecardiacfailure.DiureticAgentsOtotoxicityHearinglossordeafness,theycanbepotentiatedbyanotherototoxicdrugs(e.g.aminoglycosides).Hyperuricemiaandinducedgoutcausedbyhypovolemia-associatedenhancementofuricacidreabsorptionintheproximaltubule.DiureticAgentsOthersGIcomplaint,largedosecauseulcerandbleedingofGI.Malformation,notbeusedforpregnantwomenAgranulocytosis,DiureticAgentsBumetanide(布美他尼)Torasemide(托拉塞米)Ethacrynicacid(依他尼酸)DiureticAgentsContraindicationsTheyhavecross-reactivityinpatientswhoaresensitivetoothersulfonamides.Hepaticcirrhosis,borderlinerenalfailure,congestiveheartfailure,whenoverzealoususe.DiureticAgentsModerateefficacydiuretics(thiazides)Hydrochlorothiazide(氫氯噻嗪)Chlortalidone(氯噻酮)Bendrofluazide(芐氟噻嗪)Cyclopenthiazide(環(huán)戊噻嗪)DiureticAgentsHydrochlorothiazide(氫氯噻嗪)Allareabsorbedbygivenorally,Hydrochlorothiazideisabsorbedslowly,lessthan10%,t1/2=1.5hr,excretedunchangedintheurineandnoteffectivewhenrenalfunctionisseverelyimpaired.Itisexcretedcompeteswithuricacid,souricacidsecretoryratemaybereduced.DiureticAgentsPharmacologicaleffectsDiureticeffectmoderate,primarysiteofactionisthedistalconvolutetubule,inhibittheNa+-Cl-co-transporterintheluminalbasolateralmembranebyaNa+pumpcompetingfortheCl-bindingsitewhichisdistinctfromtheactionoftransporterintheloopofhenle.ThiazidesinhibitsodiumabsorptionbyexchangingofNa+-K+andH+-Na+.DiureticAgentsTherenalcortexhasahigh-affinityreceptorforthiazidediuretics.Variablydecreasetheglomerularfiltrationrate,butdonotaffectrenalbloodflow.EnhanceCa2+reabsorptioninthedistalconvolutedtubule,decreasesCa2+excretionfromurine.HypotensiveeffectAnti-diureticeffectDiureticAgentsUsesEdema:itisavailableusedformildandmoderatecardiacedema(congestiveheartfailure).Thediureticeffectforrenaledemadependsontherenalfunction.HypertensionDiabetesinsipidus.DiureticAgentsAdverseeffectsElectrolytedisturbanceshypokalemia,hypomagnesemia,hyponatremia,Hypovolaemia,HyperuricemiaandinducedgoutitincreasesabsorptionofuricacidandcompetesforthetransportmechanismwithuricacidDiureticAgentsHyperglycemiaandhyperlipidemiaglycosuria,aggravatespreexistingdiabetes,increasesconcentrationsofcholesterolandtriglycerides,totalcholesterolincreases.Thiazidediureticdecreaseglucosetolerance,reduceinsulinsecretionandglucoseutilization.DiureticAgentsOthersphotosensitive,thrombocytopenia,agranulocytosis,thiazideswithquinidinecanleadtopolymorphicventricular,tachycardia.DiureticAgentsLowefficacydiureticsSpironolactone(螺內(nèi)酯,antisterone安體舒通)Triamterene(氨苯喋啶)&Amiloride(阿米洛利)Acetazolamide(乙酰唑胺,diamox醋唑磺胺)DiureticAgentsThepotassium-sparingdiureticsreduceNa+absorptioninthecollectingtubulesandducts.Na+absorption(andK+secretion)atthissiteisregulatedbyaldosterone.AldosteroneenhancesK+secretionbyincreasingNa+/K+ATPaseactivityandNa+andK+channelactivities.DiureticAgentsNa+absorptioninthecollectingtubulegeneratesalumen-negativeelectricalpotential,whichenhancesK+secretion.Aldosteroneantagonistsinterferewiththisprocess.DiureticAgentsSpironolactone(螺內(nèi)酯,antisterone安體舒通)Directantagonizetheeffectsofaldosteroneatthereceptorsasacompetitiveantagonist,Itismetabolizedintheliver.Slowonesetofaction,requiringseveraldays.DiureticAgentsSpironolactonebindstocytoplasmicaldosteronereceptorsandpreventstranslocationofthereceptorcomplextothenucleus.Itmayalsoreducetheintracellularformationofactivemetabolitesofaldosteronebyinhibitionof5α-reductaseactivity.DiureticAgentsTriamterene(氨苯喋啶)&Amiloride(阿米洛利)Triamtereneismetabolizedintheliver,butrenalexcretionisamajorrouteofeliminationfortheactiveformandthemetabolites.Ithasashorterhalf-lifethanamiloride.Amilorideisexcretedunchangedintheurine.DiureticAgentsTriamtereneandamiloridedonotblockthealdosteronereceptor,directlyinterferewithNa+entrythroughthesodium-selectiveionchannelsintheapicalmembraneofthecollectingtubule.DiureticAgentsSinceK+secretioniscoupledwithNa+entryinthissegment,theseagentsarealsoeffectiveK+-sparingdiuretics.Becausetheactionsofthemaredependentonrenalprostaglandinproduction,theactionsofthemcanbeinhibitedbynonsteroidalanti-inflammtorydrugsundercertainconditions.DiureticAgentsTheyaremostusefulinstatesofmineralocorticoidexcess,dueeithertoprimaryhypersecretionortosecondareyaldosteronism.InthesettingofenhancedmineralocorticoidsecretionandcontinuingdeliveryofNa+todistalnephronsites,renalK+wastingoccurs.DiureticAgentsThisisduetoK+secondarybythecollectingtubule.K+-sparingdiureticsofeithertypemaybeusedinthissettingtoblunttheK+secretoryresponseandpreventdepletionoftheintracellularK+stores.DiureticAgentsToxicityHyperkalemiaHyperchloremicmetabolicacidosisGynecomastiaAcuterenalfailureKidneystonesDiureticAgentsContraindicationsSusceptiblehyperkalemiapatientsPatientswithchronicrenalinsufficiencyPatientswithliverdiseaseDiureticAgentsClinicalusesofdiureticsCardiacedemaRenaledemaCirrhoticedemaAcutehydrocephalusandpulmonaryedemaOsmoticAgentsOsmoticagents20%mannitol(甘露醇)25%sorbitol(山梨醇)50%glucose(葡萄糖)OsmoticAgentsTh

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論